It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
JCRRF’s FA Score shows that 1 FA rating(s) are green whileLYPHF’s FA Score has 0 green FA rating(s).
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
JCRRF’s TA Score shows that 1 TA indicator(s) are bullish while LYPHF’s TA Score has 2 bullish TA indicator(s).
JCRRF (@Pharmaceuticals: Major) experienced а 0.00% price change this week, while LYPHF (@Pharmaceuticals: Major) price change was 0.00% for the same time period.
The average weekly price growth across all stocks in the @Pharmaceuticals: Major industry was +1.04%. For the same industry, the average monthly price growth was +0.57%, and the average quarterly price growth was +9.02%.
The Major Pharmaceuticals industry includes companies that are involved in various processes of creating drugs to treat/prevent diseases. These companies engage in research, testing and manufacturing, as well as the distribution of pharmaceuticals into markets. Johnson & Johnson, Merck & Co., Inc., Pfizer Inc. and Novartis are among the largest companies in this category.
JCRRF | LYPHF | JCRRF / LYPHF | |
Capitalization | 1.2B | 1.76B | 68% |
EBITDA | 7.45B | 907M | 822% |
Gain YTD | -17.287 | -22.025 | 78% |
P/E Ratio | 44.05 | 19.23 | 229% |
Revenue | 34.3B | 5.2B | 660% |
Total Cash | 13.3B | 5.51B | 241% |
Total Debt | 22.8B | 9.49B | 240% |
JCRRF | LYPHF | |
---|---|---|
RSI ODDS (%) | N/A | N/A |
Stochastic ODDS (%) | N/A | N/A |
Momentum ODDS (%) | 5 days ago9% | N/A |
MACD ODDS (%) | N/A | N/A |
TrendWeek ODDS (%) | 5 days ago6% | 5 days ago5% |
TrendMonth ODDS (%) | 5 days ago7% | 5 days ago5% |
Advances ODDS (%) | N/A | N/A |
Declines ODDS (%) | N/A | N/A |
BollingerBands ODDS (%) | N/A | N/A |
Aroon ODDS (%) | N/A | N/A |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
RNGEX | 67.18 | 0.60 | +0.90% |
American Funds New Economy R4 | |||
OARDX | 26.54 | 0.22 | +0.84% |
Invesco Rising Dividends A | |||
TSPFX | 5.91 | 0.04 | +0.68% |
Transamerica Small Cap Growth R4 | |||
MXERX | 6.34 | 0.03 | +0.48% |
Empower S&P SmallCap 600® Index Instl | |||
SCIZX | 7.83 | 0.01 | +0.13% |
Virtus SGA International Growth R6 |
A.I.dvisor tells us that JCRRF and SNYNF have been poorly correlated (+3% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that JCRRF and SNYNF's prices will move in lockstep.
Ticker / NAME | Correlation To JCRRF | 1D Price Change % | ||
---|---|---|---|---|
JCRRF | 100% | N/A | ||
SNYNF - JCRRF | 3% Poorly correlated | +1.74% | ||
CSWYF - JCRRF | 1% Poorly correlated | N/A | ||
MIRA - JCRRF | 0% Poorly correlated | -3.23% | ||
VRBCF - JCRRF | -0% Poorly correlated | N/A | ||
LYPHF - JCRRF | -1% Poorly correlated | N/A | ||
More |
A.I.dvisor tells us that LYPHF and MRK have been poorly correlated (+20% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that LYPHF and MRK's prices will move in lockstep.
Ticker / NAME | Correlation To LYPHF | 1D Price Change % | ||
---|---|---|---|---|
LYPHF | 100% | N/A | ||
MRK - LYPHF | 20% Poorly correlated | -1.77% | ||
OGN - LYPHF | 13% Poorly correlated | -1.87% | ||
SNYNF - LYPHF | 2% Poorly correlated | +1.74% | ||
SCLX - LYPHF | 2% Poorly correlated | +1.92% | ||
CSWYF - LYPHF | 1% Poorly correlated | N/A | ||
More |